{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T07:27:09Z","timestamp":1788852429175,"version":"build-2803163510"},"reference-count":24,"publisher":"Japan Endocrine Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2017]]},"DOI":"10.1507\/endocrj.ej17-0177","type":"journal-article","created":{"date-parts":[[2017,8,2]],"date-time":"2017-08-02T00:54:36Z","timestamp":1501635276000},"page":"1033-1039","source":"Crossref","is-referenced-by-count":22,"title":["Definitive surgical treatment of osteomalacia induced by skull base tumor and determination of the half-life of serum fibroblast growth factor 23"],"prefix":"10.1507","volume":"64","author":[{"given":"Taijun","family":"Hana","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Faculty of Medicine, The University of Tokyo Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Faculty of Medicine, The University of Tokyo Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Nakatomi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Faculty of Medicine, The University of Tokyo Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Shojima","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Faculty of Medicine, The University of Tokyo Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Fukumoto","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Faculty of Medicine, The University of Tokyo Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masako","family":"Ikemura","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, The University of Tokyo Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhito","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Faculty of Medicine, The University of Tokyo Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","unstructured":"1. Folpe AL, Fanburg-Smith JC, Billings SD, Bisceglia M, Bertoni F, <i>et al<\/i>. (2004) Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature. <i>Am J Surg Pathol<\/i> 28: 1-30."},{"key":"2","unstructured":"2. Hori M, Shimizu Y, Fukumoto S (2011) Minireview:  fibroblast growth factor 23 in phosphate homeostasis and bone metabolism. <i>Endocrinology<\/i> 152: 4-10."},{"key":"3","unstructured":"3. Shimada T, Mizutani S, Muto T, Yoneya T, Hino R, <i>et al<\/i>. (2001) Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. <i>Proc Natl Acad Sci U S A<\/i> 98: 6500-6505."},{"key":"4","unstructured":"4. Endo I, Fukumoto S, Ozono K, Namba N, Inoue D, <i>et al<\/i>. (2015) Nationwide survey of fibroblast growth factor 23 (FGF23)-related hypophosphatemic diseases in Japan: prevalence, biochemical data and treatment. <i>Endocr J<\/i> 62: 811-816."},{"key":"5","unstructured":"5. Yamazaki Y, Okazaki R, Shibata M, Hasegawa Y, Satoh K, <i>et al<\/i>. (2002) Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets\/osteomalacia. <i>J Clin Endocrinol Metab<\/i> 87: 4957-4960."},{"key":"6","unstructured":"6. Yoshioka K, Nagata R, Ueda M, Yamaguchi T, Konishi Y, <i>et al<\/i>. (2006) Phosphaturic mesenchymal tumor with symptoms related to osteomalacia that appeared one year after tumorectomy. <i>Intern Med<\/i> 45: 1157-1160."},{"key":"7","unstructured":"7. Uno T, Kawai K, Kunii N, Fukumoto S, Shibahara J, <i>et al<\/i>. (2011) Osteomalacia caused by skull base tumors:  report of 2 cases. <i>Neurosurgery<\/i> 69: E239-244."},{"key":"8","unstructured":"8. Tarasova VD, Trepp-Carrasco AG, Thompson R, Recker RR, Chong WH, <i>et al<\/i>. (2013) Successful treatment of tumor-induced osteomalacia due to an intracranial tumor by fractionated stereotactic radiotherapy. <i>J Clin Endocrinol Metab<\/i> 98: 4267-4272."},{"key":"9","unstructured":"9. Mathis DA, Stehel EJ Jr, Beshay JE, Mickey BE, Folpe AL, <i>et al<\/i>. (2013) Intracranial phosphaturic mesenchymal tumors: report of 2 cases. <i>J Neurosurg<\/i> 118: 903-907."},{"key":"10","unstructured":"10. Gulwani H, Garg N (2014) A 40-year-old woman with intracranial bleed and osteomalacia. <i>Brain Pathol<\/i> 24: 419-420."},{"key":"11","unstructured":"11. Bower RS, Daugherty WP, Giannini C, Parney IF (2012) Intracranial phosphaturic mesenchymal tumor, mixed connective tissue variant presenting without oncogenic osteomalacia. <i>Surg Neurol Int<\/i> 3: 151."},{"key":"12","unstructured":"12. David K, Revesz T, Kratimenos G, Krausz T, Crockard HA (1996) Oncogenic osteomalacia associated with a meningeal phosphaturic mesenchymal tumor. Case report. <i>J Neurosurg<\/i> 84: 288-292."},{"key":"13","unstructured":"13. Chokyu I, Ishibashi K, Goto T, Ohata K (2012) Oncogenic osteomalacia associated with mesenchymal tumor in the middle cranial fossa: a case report. <i>J Med Case Rep<\/i> 6: 181."},{"key":"14","unstructured":"14. Battoo AJ, Salih S, Unnikrishnan AG, Jojo A, Bahadur S, <i>et al<\/i>. (2012) Oncogenic osteomalacia from nasal cavity giant cell tumor. <i>Head Neck<\/i> 34: 454-457."},{"key":"15","unstructured":"15. Kobayashi K, Nakao K, Kawai K, Ito K, Hukumoto S, <i>et al<\/i>. (2011) Tumor-induced osteomalacia originating from the temporal bone: a case report. <i>Head Neck<\/i> 33: 1072-1075."},{"key":"16","unstructured":"16. Kaylie DM, Jackson CG, Gardner EK (2006) Oncogenic osteomalacia caused by phosphaturic mesenchymal tumor of the temporal bone. <i>Otolaryngol Head Neck Surg<\/i> 135: 653-654."},{"key":"17","unstructured":"17. Gonzalez-Compta X, Ma&ntilde;&oacute;s-Pujol M, Foglia-Fernandez M, Peral E, Condom E, <i>et al<\/i>. (1998) Oncogenic osteomalacia: case report and review of head and neck associated tumours. <i>J Laryngol Otol<\/i> 112: 389-392."},{"key":"18","unstructured":"18. Reis-Filho JS, Paiva ME, Lopes JM (2004) August 2003: 47-year-old female with a 7-year history of osteomalacia and hypophosphatemia. <i>Brain Pathol<\/i> 14: 111-112, 115."},{"key":"19","unstructured":"19. Sandhu FA, Martuza RL (2000) Craniofacial hemangiopericytoma associated with oncogenic osteomalacia:  case report. <i>J Neurooncol<\/i> 46: 241-247."},{"key":"20","unstructured":"20. Andreopoulou P, Dumitrescu CE, Kelly MH, Brillante BA, Cutler Peck CM, <i>et al<\/i>. (2011) Selective venous catheterization for the localization of phosphaturic mesenchymal tumors. <i>J Bone Miner Res<\/i> 26: 1295-1302."},{"key":"21","unstructured":"21. Khosravi A, Cutler CM, Kelly MH, Chang R, Royal RE, <i>et al<\/i>. (2007) Determination of the elimination half-life of fibroblast growth factor-23. <i>J Clin Endocrinol Metab<\/i> 92: 2374-2377."},{"key":"22","unstructured":"22. Takeuchi Y, Suzuki H, Ogura S, Imai R, Yamazaki Y, <i>et al<\/i>. (2004) Venous sampling for fibroblast growth factor-23 confirms preoperative diagnosis of tumor-induced osteomalacia. <i>J Clin Endocrinol Metab<\/i> 89: 3979-3982."},{"key":"23","unstructured":"23. Lewerin C, Ljunggren &Ouml;, Nilsson-Ehle H, Karlsson MK, Herlitz H, <i>et al<\/i>. (2017) Low serum iron is associated with high serum intact FGF23 in elderly men: The Swedish MrOS study. <i>Bone<\/i> 98: 1-8."},{"key":"24","unstructured":"24. Shimizu Y, Fukumoto S, Fujita T (2012) Evaluation of a new automated chemiluminescence immunoassay for FGF23. <i>J Bone Miner Metab<\/i> 30: 217-221."}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/64\/10\/64_EJ17-0177\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,28]],"date-time":"2017-10-28T04:51:31Z","timestamp":1509166291000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/64\/10\/64_EJ17-0177\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej17-0177","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}